News from the life sciences and technology sectors north of Boston |
|
|
|
Yesterday, the Massachusetts Public Health Council voted to approve Dana-Farber Cancer Institute’s plans for a new $50.5 million proton therapy center at its Longwood Medical Campus. The facility, expected to open in late 2027, will use highly targeted proton beam radiation that can reduce side effects and damage to healthy tissue. The move also intensifies competition with Mass General Brigham, which operates the only currently active proton therapy center in the state. Read more in The Boston Globe. |
|
|
Congratulations to the team at Emvolon (30 Sixth Road, Woburn), which was awarded a $985,000 grant under the Massachusetts Manufacturing Innovation Initiative (M2I2) to build and deploy a pilot system that converts methane from organic waste into carbon-negative fuels. Emvolon will also collaborate with Shawsheen Valley Technical High School to provide hands-on training opportunities for students. Emvolon director of operations Vassilis Triantopoulos (center) accepted the award from Lily Fitzgerald (r), director of the Center for Advanced Manufacturing, and Zhuging Wang, senior manager, manufacturing technology and innovation for MassTech Collaborative. |
|
|
|
Azurity Pharmaceuticals (8 Cabot Road, Woburn) recently announced that ARYNTA™ (lisdexamfetamine dimesylate) Oral Solution is now available in the United States for treating ADHD in adults and pediatric patients 6 years and older. Arynta, a ready-to-use lisdexamfetamine oral solution that may be stored at room temperature, received FDA approval in June 2025. Read more. |
|
|
Kerry Love, Ph.D. (r), founder, CEO, and president of Sunflower Therapeutics (200 Boston Avenue, Medford) recently joined a panel with MIT Initiative for New Manfacturing on "Bridging Innovation and Industry" to discuss how startups are helping large manufacturers innovate. |
|
Join North Shore Technology Council, in association with MassAutonomy and MassDOT Aeronautics Division, for The Future of Flight. This interactive half-day conference will highlight technologies driving the next era of aviation. Explore real-world applications of small uncrewed aircraft systems, electric vertical takeoff and landing vehicles, and Advanced Air Mobility innovations, and see drone technology from Censys, DJI, and Skydio. Wednesday, May 21, 12:30 - 6:00 PM, Beverly Airport. Register. |
|
|
Join MassBio for the 2026 Facilities & Lab Operations Roundtable, focused on "Securing the Lab: Best Practices in Safety, Cleaning, and Emergency Preparedness." The event is open to those in lab management and operation roles at MassBio's life sciences and academic member companies. Wednesday, May 27, 12:00 - 2:00 PM, MassBioHub, 700 Technology Square, Cambridge. Register. |
|
|
Mass Innovation Network hosts Meet Your Startup Support System: FORGE, a free virtual event featuring manufacturing expert-in-residence Mark Michalski. Designed for founders involved with a physical product or hardware component, this informative event will outline how FORGE can support your commercialization journey in Massachusetts. Tuesday, June 2, 12:00 - 1:00 PM. Register. |
|
3 Gill Street, Woburn - Suites A and Z
Corner Flex and Office Suite - 7,876 SF |
|
For cleantech companies ready to scale out of an incubator, this move-in-ready flex/R&D suite offers growth potential at a fraction of the cost of leasing in Boston or Cambridge. Located at the center of a well-established climate tech community, the space offers easy access from I-95 and I-93 and a wide array of nearby amenities. |
|
Suite features include:
- Corner suite
- Two-level office suite with mezzanine offices
- 16' clear height within flex space
- Multiple loading areas
- Three overhead doors with dock-level loading
- Kitchen/break room
- Skylights
|
|
|
|
We welcome your feedback on this newsletter and invite readers to share company news, personnel changes, product launches, funding updates, events, and more. Contact Sue Howland, client engagement manager, at svh@cummings.com to offer your news for upcoming newsletters. We look forward to hearing from you. |
|
|
|
|
